Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hsc70 protein may influence hair growth by responding to androgens.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Testosterone therapy increases bone density in older men with low testosterone levels.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.